fashion -WSS

fashion

author：explore 2025-08-12 09:11:31 - browse：56446

Stacks of silver coins surrounded by a medicare health insurance card — insurance coverage from STAT — Adobe

The federal government is cutting the average benchmark payments for 2025 Medicare Advantage plans by 0.2%, according to proposed rules released by the Biden administration on Wednesday.

The slight proposed cut is mostly the result of the second year of the government’s phased-in changes to the way Medicare Advantage insurers code and report the health conditions of their members — a process known as risk adjustment. However, the government estimates Medicare Advantage plans would still cumulatively receive $16 billion more in 2025 than they got this year, assuming insurers continue their intensive coding practices.

The latest proposals reinforce how the Biden administration, as well as the Trump and Obama administrations, have bolstered Medicare Advantage even though the program costs taxpayers far more than traditional Medicare and has caused considerable concern over inappropriate denials of care. And while Biden has done more to reform Medicare Advantage than prior administrations, this set of proposals — which comes during a presidential election year — is mild.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Secretariat’s lessons for human medicine

hotspot

focus

leisure time

WSS

How to save health care price transparency rules

Ebola: Gilead Sciences antiviral shows promise as new treatment

First U.S. drug developed to treat liver disease MASH is approved

Ebola: Gilead Sciences antiviral shows promise as new treatment

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Ebola: Gilead Sciences antiviral shows promise as new treatment

leisure time

fashion

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Apple is now the first public company to be valued at $3 trillion

HHS secretary Becerra pressed on Change HealthCare cyberattack

State Dept. review finds Biden bears some blame for Afghanistan failures

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Wildfire smoke exposes gaps in outdoor worker protections

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

In age of alternative facts, a scholarly course on calling out crap

MD Anderson's Padmanee Sharma responds to research credit suit

leisure time

President Biden's budget: Here's what you might have missed

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Measles policy set amid Florida outbreak alarms vaccine proponents

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

hotspot

focus

leisure time

hotspot